Metoclopramide Injection 10mg/2ml is a sterile prescription medicine supplied in 2ml glass ampoules, with each ampoule containing 10mg of metoclopramide hydrochloride.
Metoclopramide Injection 10mg/2ml is a sterile prescription medicine supplied in 2ml glass ampoules, with each ampoule containing 10mg of metoclopramide hydrochloride. It is used in clinical settings for the prevention or management of nausea and vomiting in specific circumstances, including after surgery, during acute migraine-related nausea and vomiting, and following radiotherapy. In children and young people aged 1 to 18 years, it may also be used as a second-line option for delayed chemotherapy-induced nausea and vomiting or established post-operative nausea and vomiting. Metoclopramide injection usually begins to work within 30 to 60 minutes. Store protected from light in a cool place.
Metoclopramide Injection 10mg/2ml is intended for use by healthcare professionals in appropriate clinical settings.
In adults, it may be used where the management of nausea and vomiting is required, including after an operation, with acute migraine-related nausea and vomiting, and following radiotherapy.
In children and young people aged 1 to 18 years, metoclopramide injection is used only in limited circumstances as a second-line option, including the prevention of delayed chemotherapy-induced nausea and vomiting and the treatment of established post-operative nausea and vomiting.
This product is suitable for professional medical use where a sterile injectable antiemetic is required.
| Specification | Details |
| Strength | 10mg/2ml |
| Form | Injection |
| Active Ingredient | Metoclopramide hydrochloride BP |
| Pack Size | Pack of 10 ampoules |
| Ampoule Size | 2ml |
| Storage | Protect from light and store in a cool place |
Metoclopramide Injection is used in clinical settings for the prevention or symptomatic treatment of nausea and vomiting in adults. This includes post-operative nausea and vomiting, nausea and vomiting linked with acute migraine, and nausea and vomiting associated with radiotherapy. In children and adolescents aged 1 to 18 years, it may be used as a second-line option for delayed chemotherapy-induced nausea and vomiting or established post-operative nausea and vomiting.
Metoclopramide usually starts to work within 30 to 60 minutes.
Store in a cool place and protect from light.